2022 Volume 37 Issue 4 Pages 150-160
The strongest prognostic factor after resection of intraductal papillary mucinous neoplasms (IPMN) is the presence of invasive cancer. After resection of non-invasive IPMNs, the long-term prognosis is favorable, while extra-pancreatic recurrence or a residual pancreatic lesion might occur in some patients. Although patients with invasive IPMNs have shorter survival compared to those with non-invasive IPMNs, they have been reported to have a more favorable prognosis compared to conventional pancreatic ductal adenocarcinoma. This is probably due to detection at an earlier stage and a higher proportion of colloid carcinoma among invasive IPMNs. Residual pancreatic lesions after resection of IPMNs have increasingly been reported recently and several investigators reported risk/predictive factors. Among these, high-grade or invasive IPMNs were reported to be specific risk/predictive factors for lesions requiring resection. Regarding surveillance after resection of IPMNs, long-term surveillance considering development of residual pancreatic lesions is recommended although there are some differences in available guidelines.